Stocktoria
ACTUATE THERAPEUTICS, INC. ACTU
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-08-13
Chart by TradingView
3/9
Piotroski F — financial health
-41.61
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Operating income | -$22.5M | -$25.2M | -$25.0M |
| Net income | -$22.2M | -$27.3M | -$24.7M |
| Operating cash flow | -$19.2M | -$21.8M | -$21.6M |
| Total assets | $14.0M | $9.3M | $3.0M |
| Total liabilities | $6.1M | $9.2M | $8.4M |
| Shareholders' equity | $7.9M | $104,186 | -$99.6M |
| Ratios | |||
| Return on assets | -158.4% | -292.8% | -826.0% |
| Return on equity | -280.5% | -26189.1% | 24.8% |
| Current ratio | 2.39 | 1.05 | 0.43 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -41.61 (distress)
- Working capital / assets 0.565
- Retained earnings / assets -11.015
- EBIT / assets -1.603
- Equity / liabilities 1.296
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001652935 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.